GH
HAE icon

GAM Holding’s Haemonetics HAE Stock Holding History

GAM Holding’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-3,814
Closed -$382K – 856
2018
Q4 		$382K Sell
3,814
-2,125
-36% -$223K 0.02% 617
2018
Q3 		$680K Sell
5,939
-404
-6% -$41.8K 0.02% 587
2018
Q2 		$569K Buy
6,343
+1,159
+22% +$97.9K 0.02% 642
2018
Q1 		$379K Buy
+5,184
New +$356K 0.01% 706
2015
Q3 		– Sell
-17,400
Closed -$720K – 1132
2015
Q2 		$720K Sell
17,400
-9,800
-36% -$413K 0.01% 810
2015
Q1 		$1.22M Buy
27,200
+2,000
+8% +$83.6K 0.02% 673
2014
Q4 		$943K Sell
25,200
-12,400
-33% -$454K 0.01% 726
2014
Q3 		$1.31M Hold
37,600
– – 0.02% 628
2014
Q2 		$1.33M Hold
37,600
– – 0.02% 634
2014
Q1 		$1.23M Buy
+37,600
New +$1.44M 0.02% 639

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

GAM Holding's HAE Position: Q1 2019 in Review

GAM Holding sold out of Haemonetics (HAE) in Q1 2019, closing a stake of 3,814 shares — an estimated $382K sold.

GAM Holding first reported a position in HAE in Q1 2014 and held it in 10 quarters. The position peaked at $1.33M in Q2 2014. 260 funds tracked by Wall St. Rank hold HAE as of Q1 2019.

  • GAM Holding reported no remaining Haemonetics position as of Q1 2019 after selling out during the quarter.
  • GAM Holding sold 3,814 Haemonetics shares in Q1 2019, an estimated $382K.
  • GAM Holding first reported a position in Haemonetics in Q1 2014 and held it in 10 quarters.
  • GAM Holding's Haemonetics position peaked at $1.33M in Q2 2014.
  • 260 funds tracked by Wall St. Rank held Haemonetics as of Q1 2019.

Based on GAM Holding's 13F filing for Q1 2019, filed 10 May 2019.